Why a specific set of brain cells become vulnerable in Alzheimer’s
Metabolic Mechanisms in Locus Coeruleus Neuron Vulnerability in Neurodegenerative Disease
['FUNDING_R01'] · BROWN UNIVERSITY · NIH-11308279
This project looks at whether metabolic problems in a small group of brain cells cause early damage in people with Alzheimer’s and related diseases.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BROWN UNIVERSITY (nih funded) |
| Locations | 1 site (PROVIDENCE, UNITED STATES) |
| Trial ID | NIH-11308279 on ClinicalTrials.gov |
What this research studies
Researchers will use mouse models that mimic Alzheimer’s and related conditions to study why the locus coeruleus — a small but important group of brain cells — breaks down early in the disease. They focus on a mitochondrial enzyme called GPT2 because mice lacking this enzyme show very early loss of these cells. The team will compare Gpt2-null mice with other Alzheimer’s and Down Syndrome models across different ages and perform gene-by-environment experiments to see what speeds vulnerability. The goal is to find metabolic steps that make these cells fragile so future therapies might protect them.
Who could benefit from this research
Good fit: People with Alzheimer’s disease, related dementias, or genetic risk factors for these conditions are the populations this research ultimately aims to help.
Not a fit: People looking for immediate treatments or those without neurodegenerative disease are unlikely to directly benefit from this preclinical, animal-based research.
Why it matters
Potential benefit: If successful, this work could identify metabolic targets to protect vulnerable brain cells early in Alzheimer’s and open new paths for treatments to slow disease progression.
How similar studies have performed: Previous studies have linked locus coeruleus loss and mitochondrial dysfunction to Alzheimer’s, but targeting GPT2 and its role in very early cell loss is a novel angle.
Where this research is happening
PROVIDENCE, UNITED STATES
- BROWN UNIVERSITY — PROVIDENCE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MORROW, ERIC M — BROWN UNIVERSITY
- Study coordinator: MORROW, ERIC M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome